Scott Rottinghaus
Chief Tech/Sci/R&D Officer presso ENANTA PHARMACEUTICALS, INC.
Patrimonio netto: 493 891 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Scott Rottinghaus
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 13 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Scott Rottinghaus tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
XENCOR, INC. | Biotechnology | Chairman Director/Board Member | |
TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
Experimed Bioscience, Inc.
Experimed Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Experimed Bioscience, Inc. engages in research and development of drugs. The company was founded by Schepartz Alanna and is headquartered in South San Francisco, CA | Pharmaceuticals: Major | Director/Board Member | |
BioMotiv LLC
BioMotiv LLC BiotechnologyHealth Technology BioMotiv LLC operates as a research institution in the field of therapeutics. It focuses in disease areas and classes of therapeutics such as small molecules, antibodies, proteins, and nucleotides. The company was founded on September 10, 2012 and is headquartered in Cleveland, OH. | Biotechnology | Corporate Officer/Principal | |
VALERITAS HOLDINGS, INC. | Medical Specialties | Chief Executive Officer | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Stanford University | College/University | Masters Business Admin | |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Financial Conglomerates | Corporate Officer/Principal | |
University of Oxford | College/University | Undergraduate Degree | |
Drexel University | College/University | Undergraduate Degree | |
HealthCare IT, Inc.
HealthCare IT, Inc. Information Technology ServicesTechnology Services HealthCare IT, Inc. provides biomedical research software and healthcare managed hosting services. The company is headquartered in Columbia, MD. | Information Technology Services | Director/Board Member | |
EYEPOINT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Colgate University | College/University | Undergraduate Degree | |
The Colorado College
The Colorado College Other Consumer ServicesConsumer Services Colorado College provide a broad liberal arts education to students. The college was founded in May 6, 1874 and it is headquartered in Colorado Springs, CO | College/University | Undergraduate Degree | |
The University of Chicago | College/University | Doctorate Degree | |
Princeton University | College/University | Undergraduate Degree | |
University of California San Diego | College/University | Corporate Officer/Principal | |
EGS Healthcare Capital Partners LLC
EGS Healthcare Capital Partners LLC Investment ManagersFinance EGS Healthcare Capital Partners LLC (EGS Healthcare Capital Partners) is a private equity firm founded in 1999 by Frederic Greenberg and Terry C. Vance. The firm is headquartered in Rowayton, Connecticut. | Investment Managers | Founder | |
Eagle Strategic Advisers LLC | Corporate Officer/Principal | ||
Saints Ventures LLC
Saints Ventures LLC Investment ManagersFinance Saints Ventures LLC (Saints Ventures) is a private equity/venture capital firm founded in 2000 by Ken Sawyer and David Quinlivan. The firm is headquartered in Denver, Colorado. | Investment Managers | Private Equity Investor | |
Mountain Group Capital LLC
Mountain Group Capital LLC Investment ManagersFinance Mountain Group Capital LLC (Mountain Group Capital) is a venture capital investment firm founded in 2002. The firm is headquartered in Nashville, Tennessee. | Investment Managers | Corporate Officer/Principal | |
Schering-Plough Pharmaceuticals | Portfolio Manager-Fixed Income | ||
REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
The Leonard N Stern School of Business | College/University | Masters Business Admin | |
PARATEK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
RAPT THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Founder | |
Expansion Therapeutics, Inc.
Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA. | Pharmaceuticals: Major | Director/Board Member | |
SapVax LLC
SapVax LLC Pharmaceuticals: MajorHealth Technology SapVax LLC develops a platform for generating peptide-based, self-adjuvanting cancer vaccines. Its platform is based on a flexible synthetic method for linking tumor antigens with an adjuvant, which enables the generation of vaccines targeting virtually any peptide tumor antigen. The company was founded by Rod Dunbar and Margaret Brimble in 2016 and is headquartered in Cleveland, OH. | Pharmaceuticals: Major | President | |
AFYX Therapeutics AS
AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Miscellaneous Commercial Services | Director/Board Member | |
University of Illinois At Urbana–Champaign | College/University | Masters Business Admin | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member | |
ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 46 |
Regno Unito | 4 |
Australia | 2 |
Danimarca | 2 |
Settori
Health Technology | 25 |
Consumer Services | 13 |
Finance | 6 |
Commercial Services | 5 |
Technology Services | 3 |
Posizioni
Director/Board Member | 60 |
Corporate Officer/Principal | 31 |
Independent Dir/Board Member | 28 |
Undergraduate Degree | 12 |
Chief Tech/Sci/R&D Officer | 11 |
Contatti più connessi
Insiders | |
---|---|
Bruce Carter | 25 |
Lesley Russell | 19 |
Mark Foletta | 18 |
Kristine Peterson | 18 |
Terry Vance | 16 |
Yujiro Hata | 14 |
Jay Luly | 8 |
Paul Mellett | 7 |
Nathaniel Gardiner | 7 |
Yat Sun Or | 4 |
Tara Kieffer | 4 |
Brendan Luu | 4 |
Jennifer Viera | 3 |
- Borsa valori
- Insiders
- Scott Rottinghaus
- Connessioni Società